What is Nightmare PTSD Phase 3 Clinical Trial?

Category: Others

false

NCT02236390 Integrating Sleep, Nightmare and PTSD Treatments is a randomized single blinded efficacy study. Specific behavioral interventions are evaluated to measure frequency of nightmares and presence of PTSD symptoms.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Nightmare PTSD Phase 3 Clinical Trial

Side effect Patients
Persistent worrying 1

Dosages

Based on patients currently using Nightmare PTSD Phase 3 Clinical Trial

Dosage Patients
every other week 1

Duration

Currently using Nightmare PTSD Phase 3 Clinical Trial

Duration Patients
2 - 5 years 1
Adherence
Adherence Evaluations
Always 0
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 0
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0
Last updated:
There are no evaluations for Nightmare PTSD Phase 3 Clinical Trial.